Medicine Man Technologies, Inc.
SHWZ
$0.02
$0.01100.00%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 8.27% | 16.10% | 23.25% | 38.58% | 47.03% |
| Total Other Revenue | -28.21% | 38.32% | 55.23% | 99.01% | 35.27% |
| Total Revenue | 8.20% | 16.14% | 23.31% | 38.68% | 47.00% |
| Cost of Revenue | 21.92% | 4.70% | 4.03% | 10.91% | 33.90% |
| Gross Profit | -5.31% | 28.28% | 44.96% | 74.18% | 62.68% |
| SG&A Expenses | 19.37% | 26.94% | 25.05% | 32.96% | 52.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.82% | 13.77% | 12.87% | 19.82% | 41.32% |
| Operating Income | -75.60% | 31.94% | 132.75% | 340.72% | 100.46% |
| Income Before Tax | -314.87% | -138.57% | -137.55% | 931.43% | -118.87% |
| Income Tax Expenses | 32.50% | 38.28% | 103.02% | 251.96% | 238.89% |
| Earnings from Continuing Operations | -87.08% | -249.87% | -245.69% | 216.80% | -227.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -87.08% | -249.87% | -245.69% | 216.80% | -227.20% |
| EBIT | -75.60% | 31.94% | 132.75% | 340.72% | 100.46% |
| EBITDA | -26.64% | 34.39% | 124.90% | 201.42% | 86.84% |
| EPS Basic | -26.69% | -522.51% | -462.77% | 132.74% | -399.20% |
| Normalized Basic EPS | -179.28% | -106.38% | -93.55% | 2,101.90% | -55.97% |
| EPS Diluted | 25.01% | -94.69% | -97.30% | 33.14% | -5,376.51% |
| Normalized Diluted EPS | 45.63% | 15.48% | 27.02% | 160.96% | -444.28% |
| Average Basic Shares Outstanding | 35.17% | 35.46% | 21.19% | 19.47% | 17.20% |
| Average Diluted Shares Outstanding | -2.07% | -36.50% | -22.48% | 12.89% | -0.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
